Abstract OBJECTIVE: To study the clinical manifestations and neuroimaging characteristics of pediatric moyamoya disease. METHODS: The clinical data of 17 children with moyamoya disease were retrospectively studied. RESULTS: The onset age was between 3 and 14 years. The main clinical manifestations included motor weakness of extremities or hemiplegia, sensory disturbance and headache. Cranial CT or/and MRI examinations predominately showed cerebral infarct. Magnetic resonance angiography (MRA) and digital subtraction angiography (DSA) showed stenosis or occlusion at the terminus of the siphon portions of internal carotid arteries and proximal portions of anterior or middle cerebral arteries, and abnormal vascular networks at the base of brain. CONCLUSIONS: Cerebral ischemia is main clinical manifestations in children with moyamoya disease, presenting motor weakness of extremities or hemiplegia, sensory disturbance and headache. DSA is essential to the diagnosis of the disease.［Chin J Contemp Pediatr, 2010, 12 (8):637-640］
LI Jie,LIU Rui,LI Zhu-Yi et al. Clinical manifestations and neuroimaging characteristics of children with moyamoya disease[J]. 中国当代儿科杂志, 2010, 12(08): 637-640.
LI Jie,LIU Rui,LI Zhu-Yi et al. Clinical manifestations and neuroimaging characteristics of children with moyamoya disease[J]. CJCP, 2010, 12(08): 637-640.
［1］Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain［J］. Arch Neurol, 1969, 20(3):288-299.
［3］Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan［J］. Clin Neurol Neurosurg, 1997, 99(2): s238-240.
［4］Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK. Familial occurrence of moyamoya disease: a clinical study［J］. Childs Nerv Syst, 2006, 22(9):1143-1148.
［5］Yanagawa Y, Sugiura T, Suzuki K, Okada Y. Moyamoya disease associated with positive findings for rheumatoid factor and myeloperoxidaseantineutrophil cytoplasmic antibody［J］. West Indian Med J, 2007, 56(3):282-284.
［7］Desai SS, Paulino AC, Mai WY, Teh BS. Radiation-induced moyamoya syndrome［J］. Int J Radiat Oncol Biol Phys, 2006, 65 (4): 1222-1227.
［8］Matsushima Y, Qian L, Aoyagiu M. Comparison of moyamoya disease in Japan and moyamoya disease (or syndrome)in the People's Republic of China ［J］. Clin Neuro Neurosurg, 1997, 99 (Suppl 2): S19-S22.
［10］Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography ［J］. Radiology, 1995, 196(1): 211-218.
［11］Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment［J］. Neurosurgery, 2004, 54 (4): 840-844.
［12］Ozgur BM, Aryan HE, Levy ML. Indirect revascularization for paediatric moyamoya disease: the EDAMS technique［J］. J Clin Neurosci, 2006, 13(1): 105-108.
［13］Isono M, Ishii K, Kamida T, Inoue R, Fujiki M, Kobayashi H. Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis［J］. Pediatr Neurosurg, 2002, 36(1): 14-21.
